Pfizer and Sun settle Bosulif dispute

06-11-2019

Rory O'Neill

Pfizer and Sun settle Bosulif dispute

photobyphm / Shutterstock.com

Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.


Pfizer, Sun Pharma, Bosulif, bosutinib, ANDA, settlement, Lyrica, pregabalin

More on this story

Sun Pharma takes Pfizer to court over Lyrica
08-04-2019

LSIPR